PDK1 and myeloid sarcoma: Pyruvate dehydrogenase kinase 1 (PDK1), the enzyme that inhibits PDH activity and was previously shown to be upregulated in activated innate immune cells in an MS model, was increased in untreated CPZ-EAE mice compared to control mice (Fig. 3g, +95 fold, p < 0.0001).